Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Evans Terry L received 168 Fennec Pharmaceuticals Inc. shares as an award (Form 4)

Traded May 31, 2026 · Filed Jun 1, 2026

On May 31, 2026, Evans Terry L (Chief Commercial Officer) received 168 Fennec Pharmaceuticals Inc. shares as an award, leaving 21,015 shares. Filed Jun 1, 2026 (Form 4).

Awarded
168 shares
Holding after
21,015 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 31, 2026Common SharesAward16821,015Direct

Source

View original at SEC

Related